Rein Therapeutics share price logo

Rein Therapeutics

NASDAQ: RNTX

$0.75

+0.00

(+0.59%)

as on

Rein Therapeutics Stock Performance

as on September 26, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $0.73
    $0.82
    downward going graph

    2.46%

    Downside

    9.57%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.69
    $2.18
    downward going graph

    7.27%

    Downside

    191.29%

    Upside

    downward going graph

Rein Therapeutics share price movements today

Previous Close
$0.74
Open
$0.78
Volume
321.1K
Market Cap
$66.5M
Day's Low - High
$0.73 - $0.82
52 Week Low - High
$0.69 - $2.18

Rein Therapeutics Historical Returns

1 Month Return
-7 %
3 Month Return
-20.46 %
1 Year Return
-37.74 %
3 Year Return
0 %
5 Year Return
0 %

Rein Therapeutics Stock Fundamentals & Key Indicators

Check Rein Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$66.5M

EPS (TTM)

-1.83

Dividend Yield

0.00%

PE Ratio (TTM)

-0.42

Industry PE ratio

-2.69

PEG Ratio

-0.011523791986759731

Return On Equity TTM

-234.45%

Rein Therapeutics Stock Valuation

Track how Rein Therapeutics P/E has moved over time to understand its valuation trends.

Rein Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-619.61x)

March 31, 2024

Industry (-2.69x)

March 31, 2026

Today (-0.59x)

March 31, 2026

Highest (-0.59x)

March 31, 2026

LowHigh

Today’s Price to Earnings Ratio: -0.59x

Rein Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rein Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$66.5MNA-0.420.00%0.00%
Neutral$77.8B-53.76%-24.41-12.57%0.00%
StrongBuy$132.4B186.58%30.1686.04%0.00%
Buy$82.8B23.34%19.0184.86%0.46%

Stock Returns calculator for Rein Therapeutics Stock including INR - Dollar returns

The Rein Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Rein Therapeutics investment value today

Current value as on today

₹67,598

Returns

-₹32,402

(-32.4%)

Returns from Rein Therapeutics Stock

-₹37,372 (-37.37%)

Dollar Impact

₹4,970 (+4.97%)

Indian Investors' Interest in Rein Therapeutics Stock

Search interest for Rein Therapeutics Stock has increased by 51% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:51% versus previous 30 day period

Rein Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
0
0
0
0
-6
-5
-6
-5
-5
-6
EBITDA
0
0
0
0
-5
-5
-6
-5
-5
-6
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
-
-
0
-
0
-
Income Before Tax
0
0
0
0
-5
-5
-6
-5
-5
-6
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
0
0
0
0
-5
-5
-6
-5
-5
-6
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Rein Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
-
-
-
0
Operating Income
-31
-29
0
0
0
0
-65
-21
EBITDA
-31
-29
0
0
0
0
-28
-50
Interest Expense
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-31
-29
0
0
0
0
-64
-50
Income Tax Expense
0
0
-
-
-
-
-1
0
Net Income
-31
-28
0
0
0
0
-62
-49
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Rein Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Net Income
-1
-1
-7
-8
-5
-5
-6
-5
-5
-6
Operating Cash Flow
-3
-1
-5
-8
-3
-6
-6
-3
-3
-8
Investing Cash Flow
8
0
-
-
-
-
-
-
-
-35
Financing Cash Flow
-
-
-
18
0
0
4
1
4
47
Change in Cash
5
-1
-5
9
-4
-5
-1
-1
1
4

Rein Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Income
-31
-29
-21
-26
-27
-15
-62
-49
Operating Cash Flow
-27
-26
-20
-23
-24
-19
-22
-19
Investing Cash Flow
24
-2
6
-35
26
16
-
-
Financing Cash Flow
2
23
15
55
-
15
17
9
Change in Cash
0
-5
1
-4
1
12
-4
-9

Mutual Funds that own Rein Therapeutics Stock

Check out the Mutual Funds with significant holdings in Rein Therapeutics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
1.157476%
998521
Fidelity Concord Street Trust
0.214049%
184654

Global Institutional Holdings in Rein Therapeutics

Funds
Holdings
Vanguard
3.84%
VANGUARD INDEX FUNDS
1.16%
Fidelity Concord Street Trust
0.21%
iShares
0.1%
Fidelity
0.09%

Insights on Rein Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 748.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 102.7% return, outperforming this stock by 152.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, RNTX stock has moved down by -6.5%

About Rein Therapeutics

Rein Therapeutics Inc. operates as a clinical-stage biopharmaceutical enterprise focused on discovering and bringing to market novel therapeutic solutions for various conditions, notably cancer. The company's leading drug candidate, ALRN-6924, is a distinctive cell-penetrating peptide. This compound works by disrupting the harmful interaction between the p53 suppressor proteins, MDM2 and MDMX, and the vital p53 tumor suppressor. Its goal is to reactivate the natural tumor-suppressing pathways in cancers where the p53 gene is still functional, or "wild-type." The organization was founded on August 6, 2001, by Gregory L. Verdine, Rosana Kapeller, Huw M. Nash, Joseph A. Yanchik III, and Loren David Walensky, and its main corporate offices are situated in Austin, Texas.
OrganisationRein Therapeutics
Headquarters12407 N. Mopac Expy., Austin, TX, 78758, US
IndustryBiotechnology
CEOJames Brian Windsor
E-voting on sharesClick here to vote

Key Management of Rein Therapeutics

Name

Title

Dr. James Brian Windsor Ph.D.

CEO, President & Director

Dr. Cory M. Hogaboam Ph.D.

Chief Scientific Officer

Ms. Jennifer Faigle

Counsel

Mr. Ron Chen

VP of Finance and Corporate Controller

FAQs

What is Rein Therapeutics share price today?

Rein Therapeutics share price today is $0.75 as on at the close of the market. Rein Therapeutics share today touched a day high of $0.82 and a low of $0.73.

What is the 52 week high and 52 week low for Rein Therapeutics share?

Rein Therapeutics share touched a 52 week high of $2.18 on and a 52 week low of $0.69 on . Rein Therapeutics stock price today i.e. is closed at $0.75,which is 65.67% down from its 52 week high and 7.84% up from its 52 week low.

What is Rein Therapeutics's market capitalisation today?

Rein Therapeutics market capitalisation is $0.00T as on .

How to invest in Rein Therapeutics Stock (RNTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Rein Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rein Therapeutics Shares that will get you 2.0043 shares as per Rein Therapeutics share price of $0.75 per share as on September 26, 2026 at 8:45 am IST.

What is the minimum amount required to buy Rein Therapeutics Stock (RNTX) from India?

Indian investors can start investing in Rein Therapeutics (RNTX) shares with as little as ₹95.8125 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.13 in Rein Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Rein Therapeutics share’s latest price of $0.75 as on September 26, 2026 at 8:45 am IST, you will get 13.3618 shares of Rein Therapeutics. Learn more about fractional shares .